Nerve-cell injury marker linked to death risk at ages 92–107
Higher marker levels were linked to higher mortality, with reported hazard ratios (relative death-rate measures) of 1.21 to 1.38 across three cohorts.
Limit: The Dutch cohort included only cognitively healthy centenarians, leaving out those with cognitive impairment
An observational study followed 559 people aged 92–107 from three cohorts for up to 16 years. These included cognitively healthy Dutch centenarians and two population-based Danish groups. Researchers assessed blood neurofilament light, a marker of injury to nerve-cell fibers, alongside cognition and ability to carry out daily activities. They also assessed Alzheimer’s disease blood markers in the Dutch cohort.
Neurofilament light was the only blood marker consistently associated with mortality. Its association remained after accounting for cognition and daily functioning. In the Dutch cohort, Alzheimer’s-specific blood markers did not predict mortality, despite reflecting Alzheimer’s-related brain changes found in examinations after death.
Why it matters
The study addresses whether vulnerability at extreme ages relates more closely to nerve-cell injury than to Alzheimer’s-related brain changes, and how this differs from declines in thinking and everyday functioning.
Caveats
This observational study could not establish causation, and its findings concern people aged 92–107, not younger populations. The report is a preprint and has not been peer-reviewed.
The paper
Amsterdam UMC, Vrije Universiteit Amsterdam
medRxiv, Oct 19, 2026, Open access, CC BY-NC-ND, Preprint, not peer-reviewed
